Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

NCT00919503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Non-Neoplastic Hematologic and Lymphocytic Disorder

Interventions

PROCEDURE: Allogeneic Bone Marrow Transplantation
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclosporine
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Methotrexate
DRUG: Mycophenolate Mofetil
PROCEDURE: Peripheral Blood Stem Cell Transplantation
DRUG: Tacrolimus
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Umbilical Cord Blood Transplantation

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]